金禧國際控股(00091.HK)斥2300萬元收購10條熔噴布生產線
格隆匯9月1日丨金禧國際控股(00091.HK)公告,於2020年9月1日,買方湖南碩華環保新材料有限責任公司(公司間接全資附屬公司)與賣方湖南晟海新材料有限公司訂立購買合約,以收購合共10條熔噴布生產線,總合約價人民幣2300萬元。
自新型冠狀病毒病(COVID-19)於2020年年初爆發以來,公司注意到全球各地對個人防護裝備及設備的需求迅速增加。有見及此,董事認為,用作口罩過濾層的熔噴布的需求亦顯著上升。董事相信,開展熔噴布生產將豐富集團自身有力生產的產品種類,預計可帶動可持續業務增長。預期將於2020年第四季度於中國湖南省開展試生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.